It is reported that inhibitors of CTLA-4, LAG-3, PD-1, PD-L1 and other immune checkpoints have been shown to improve the OS of patients with advanced ccRCC [15, 30, 31]. Here, LAG3 is linked to nonpapillary renal cell carcinoma.